Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | CC-96191 |
Synonyms | |
Therapy Description |
CC-96191 is a tri-specific antibody targeting CD33, NKG2D, and CD16a, which activates natural killer (NK) cells and potentially induces lysis of CD33-positive tumor cells (PMID: 38473239). |